ClinicalTrialStartPulse / compare
Janssen Research & Development, LLC vs Enanta Pharmaceuticals, Inc: ClinicalTrialStartPulse comparison
Janssen Research & Development, LLC's enrollment of 864 is 1.0x Enanta Pharmaceuticals, Inc's 860 (93rd percentile). Janssen Research & Development, LLC is dated 2026-11-03; Enanta Pharmaceuticals, Inc 2026-11-02.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
Both records plus every comparable US record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe
How does Janssen Research & Development, LLC compare to Enanta Pharmaceuticals, Inc?
| Field | Janssen Research & Development, LLC | Enanta Pharmaceuticals, Inc |
|---|---|---|
| Sponsor | Janssen Research & Development, LLC | Enanta Pharmaceuticals, Inc |
| Sponsor type | Industry (pharma, biotech, medtech) | Industry (pharma, biotech, medtech) |
| Study | A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment | A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease |
| NCT ID | NCT05455320 | NCT07908381 |
| Phase | Phase 3 | Phase 3 |
| Status | active not recruiting | recruiting |
| Conditions | Multiple Myeloma | RSV |
| Intervention types | drug | drug |
| Target enrollment | 864 | 860 |
| Site countries | United States, Belgium, Brazil, China, Czechia, France, Germany, Greece, Israel, Italy, Japan, Netherlands | United States |
| Posted | 2022-07-13 | 2026-11-02 |
| Planned start | 2022-10-13 | 2026-10-19 |
| Event | Enrollment closed (active, not recruiting) | Newly registered study |
| Event date | 2026-11-03 | 2026-11-02 |
| Last update posted | 2026-11-03 | |
| enrollment percentile | 93rd | 93rd |
| Score | 100/100 | 90/100 |
| Peer rank and all 500 US records (CSV) | 🔒 Click to unlock → | |
| Official source URLs for every peer record | 🔒 Click to unlock → | |
Official records: Janssen Research & Development, LLC · Enanta Pharmaceuticals, Inc
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.